MiNK Therapeutics, Inc.
INKT
$11.65
-$0.53-4.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.89M | -4.24M | -2.77M | -2.46M | -1.81M |
| Total Depreciation and Amortization | 43.70K | 48.80K | 50.80K | 53.90K | 62.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 841.70K | 1.45M | 784.00K | 703.00K | -1.19M |
| Change in Net Operating Assets | 1.06M | 1.17M | 591.00K | -21.40K | -60.00K |
| Cash from Operations | -941.30K | -1.57M | -1.34M | -1.73M | -2.99M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 13.55M | 500.00 | 600.00 | -- | 6.80K |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.55M | 500.00 | 600.00 | 0.00 | 6.80K |
| Foreign Exchange rate Adjustments | -5.00K | 15.70K | -1.80K | -23.50K | 2.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.60M | -1.55M | -1.34M | -1.75M | -2.99M |